Impax Investor Attys Score $9.9M Fees In Price-Fixing Suit
A California federal judge on Friday granted $9.9 million in attorney fees and gave final approval to a $33 million settlement that resolves claims that generic-drug maker Impax Laboratories Inc. failed...To view the full article, register now.
Already a subscriber? Click here to view full article